JPRN-UMIN000009427已完成1 期
Phase I interaction study of docetaxel with supplementation of St. John's wort or Echinacea - Interaction study of docetaxel and St. John's wort or Echinacea
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •- Any treatment with investigation drugs within 30 days before the start of the study - Concomitant use of MDR and CYP3A modulating drugs - Unresolved (>grade 1) toxicities of previous chemotherapy - Chronic use of H2-receptor antagonists or proton pump inhibitors - Use of herbal supplements, especially St. John's wort or Echinacea, within 6 weeks prior to study treatment.
研究者
相似试验
尚未招募
不适用
Phase I interaction study of Docetaxel with supplementation of St. John*s wort or Echinaceamalignant tumors10027655cancerNL-OMON32425Antoni van Leeuwenhoek Ziekenhuis20
已完成
不适用
Phase I/II study of the combination of docetaxel, CDDP and S-1 in patients with unresectable advanced gastric cancerunresectable advanced gastric cancerJPRN-C000000080Fourth Department of Internal Medicine, Sapporo Medical University40
已完成
2 期
Phase II study of the combination of docetaxel, cisplatin plus S-1(DCS) for advanced or recurrent gastric cancer(KDOG 0601)Gastric cancerJPRN-UMIN000001119Department of Gastroenterology, Kitasato University School of Medicine45
招募中
不适用
Phase I interaction study of Docetaxel and Tolbutamide with supplementation of Milk Thistlemalignant tumors10006291cancerNL-OMON39305Antoni van Leeuwenhoek Ziekenhuis10
招募中
1 期
Investigation of therapeutic efficacy of docetaxel, cisplatin and S1 (DCS) chemotherapy for advanced or recurrent gastric cancerAdvanced/Recurrent Gastric cancerJPRN-UMIN000019972Teikyo University Chiba Medical Center40